Back to funds
View filing
Blue Owl Capital Holdings LP
hedge fundUpdated 30 days agoManaged by Blue Owl Capital Holdings Lp • Latest filing Q2 2026
Portfolio value
$664.5M
Q2 2026
Filings
14
Quarterly 13F history
Top-10 concentration
99.0%
Weight of largest holdings
Annualized return
33.6%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 14 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q1 2023 | $156.1M |
| Q2 2023 | $162.3M |
| Q3 2023 | $129.3M |
| Q4 2023 | $418.3M |
| Q1 2024 | $500.6M |
| Q2 2024 | $359.6M |
| Q3 2024 | $518.4B |
| Q4 2024 | $434M |
| Q1 2025 | $310.1M |
| Q2 2025 | $309.9M |
| Q3 2025 | $322.1M |
| Q4 2025 | $1.3B |
| Q1 2026 | $372.2M |
| Q2 2026 | $664.5M |
Top holdings
76 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | S SPCX SPACE EXPLORATION TECHN CORP | $239M | 1.40M | 35.97% | — |
| 2 | A AKTS AKTIS ONCOLOGY INC | $99M | 3.07M | 14.89% | — |
| 3 | C CGEM CULLINAN THERAPEUTICS INC | $28M | 1.54M | 4.22% | — |
| 4 | L LRMR LARIMAR THERAPEUTICS INC | $27.9M | 9.16M | 4.21% | — |
| 5 | N NCDL NUVEEN CHURCHILL DIRECT LEND | $26.6M | 2.14M | 4.01% | — |
| 6 | M MPLT MAPLIGHT THERAPEUTICS INC | $26.2M | 729.9K | 3.94% | — |
| 7 | C COF-PN CAPITAL ONE FINL CORP | $24M | 119.8K | 3.62% | — |
| 8 | O OBDC BLUE OWL CAPITAL CORPORATION | $22.2M | 2.05M | 3.35% | — |
| 9 | ? N/A DEEP FISSION INC | $14.7M | 1.33M | 2.22% | — |
| 10 | D DELL DELL TECHNOLOGIES INC | $14.2M | 33.0K | 2.14% | — |
| 11 | H HLLY HOLLEY INC | $11.2M | 4.38M | 1.68% | — |
| 12 | ? N/A EYEPOINT INC | $10.9M | 762.6K | 1.64% | — |
| 13 | S SGMT SAGIMET BIOSCIENCES INC | $9.7M | 1.26M | 1.47% | — |
| 14 | C CRVS CORVUS PHARMACEUTICALS INC | $9.1M | 608.6K | 1.37% | — |
| 15 | ? N/A ARTIVA BIOTHERAPEUTICS INC | $8.5M | 874.5K | 1.28% | — |
| 16 | ? N/A COMPASS THERAPEUTICS INC | $7.9M | 3.62M | 1.19% | — |
| 17 | C CNDT CONDUENT INC | $7.4M | 5.04M | 1.11% | — |
| 18 | R RYTM RHYTHM PHARMACEUTICALS INC | $6.8M | 61.5K | 1.03% | — |
| 19 | C CMPS COMPASS PATHWAYS PLC | $6.4M | 450.0K | 0.96% | — |
| 20 | R RARE ULTRAGENYX PHARMACEUTICAL IN | $6.1M | 182.6K | 0.92% | — |